Moreover, hsa-miR-101-3p can inhibit MALAT1, BCL2, MMP9, PI3K (PIK3CA) expressions in NSCLC cell lines (H1299 and H520) [77]. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.